ABCL insider trading
AbCellera Biologics Inc.
In the past 68 days, 2 insiders bought $796K of AbCellera Biologics Inc. stock in 2 open-market purchases. The largest purchase was $699K by Thermopylae Holdings Ltd. (10% owner) on Nov 12, 2026.
Insider purchases
| Insider | Value | Holdings | Signal | Traded / filed |
|---|---|---|---|---|
Andrew Booth Chief Financial Officer |
$97K 8,600 sh @ $11.33 |
+1.8% | Low
|
Nov 13, 2026 Filed Nov 13, 2026 |
Thermopylae Holdings Ltd. 10% owner |
$699K 60,565 sh @ $11.54 |
+0.1% | Low
|
Nov 12, 2026 Filed Nov 12, 2026 |
Insider sales
No open-market sales by insiders in this period.
The week's top insider buys, every Monday
Clusters, CEO purchases and the largest buys from the past week's SEC filings. One free email a week.
Unsubscribe any time. No spam, no stock picks.